N,N-二甲基-5-(1H-1,2,4-三氮唑-1-基甲基)-1H-吲哚-3-基乙胺苯甲酸盐; 利扎曲坦苯甲酸盐; 苯甲酸利扎曲普坦; N,N-二甲基-2-[5-(1,2,4-三氮唑-1-基甲基)-1H-吲哚-3-基]乙胺苯甲酸盐; 苯甲酸利扎曲谱坦; N,N-二甲基-5-(1H-1,2,4-三唑-1-基甲基)-1H-吲哚-3-乙胺・单苯甲酸盐
Rizatriptan benzoate salt; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine monobenzoate; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine benzoate; Rizatriptan benzoate; 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1); N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine benzoate (1:1); Maxalt; MK-462 (N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt; Rizatrimptan benzoate; MFCD00866224; Benzolcarbonsäure--N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamin(1:1); N,N-diméthyl-2-[5-(1H-1,2,4-triazol-1-ylméthyl)-1H-indol-3-yl]éthanamine benzoate; Rizatriptan; N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine Benzoate; MAXALT; RIZATRIPTANE BENZOATE; N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE, BENZOATE; n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethylamine benzoate; MK-0462; MK-462; Rizatrimptan Benzoate; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; N,N-dimethy1-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine monobenzoate
-20°C Freezer
水溶性:可溶;水溶解度:53 g/l ;可溶于:甲醇;微溶:乙醇;不溶:乙醚
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:5 4.可旋转化学键数量:6 5.互变异构体数量:无 6.拓扑分子极性表面积87 7.重原子数量:29 8.表面电荷:0 9.复杂度:412 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2